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Key point 
REACH is a very demanding system for any business either large or small, yet right from the start 
one of the more serious concerns was whether and how SMEs could cope with the Regulation. 
After all, some 27,600 companies in EU chemistry are SMEs (95% of all firms). Seven years down 
the line, many of these fears are materialising. Assuming no significant changes are introduced to 
REACH, we suggest the following recommendations: 
Recommendations 
  Above  all,  SMEs  are  strongly  encouraged  to  start  early  to  develop  a  strategy  for  REACH 
compliance well before 2018.  
  The potential competition law implications of current SIEF (Substance  Information  Exchange 
Forum)  arrangements  need  to  be  addressed,  e.g.  through  a  Guidance  document  from  DG 
Competition by 2014 (in time for 2018). 
  The exchange of information all along the value chain needs to be facilitated by adopting a 
pragmatic approach to the content and format of Safety Data Sheets. More can be done on the 
IT front as well, for instance by developing tools that generate compliant Safety Data Sheets. 
  Communication  about  REACH,  especially  its  intended  goals,  namely  the  health  and 
environmental benefits, needs to be significantly improved vis-à-vis the wider public. SMEs 
regret the lack of awareness on the part of the public in light of the enormous compliance 
efforts they have to undertake. 
  In the event of a later review of REACH, the logic should be risk-based rather than hazard-
based.  2 | GUBBELS, PELKMANS & SCHREFLER 
 
 
1.  The REACH problem for SMEs 
Right  from  the  start  of  the  REACH  debate, 
following  the Commission proposal  of  October 
2003,  one  of  the  more  serious  concerns  was 
whether  and  how  SMEs  could  cope  with 
REACH. Indeed, there were doubts whether one 
of  the  main  objectives  of  REACH  – 
competitiveness  of  chemical  and  downstream 
companies  –  is  consistent  with  the  design  and 
detailed implementation of REACH. Already in 
2005,  the  European  Parliament  adopted  a 
resolution on this aspect, insisting e.g. on lower 
fees  for  SMEs  as  one  remedy  to  reduce  the 
expected  regulatory  burden  for  smaller 
companies.  The  fear  of  REACH  being  unduly 
heavy and costly for SMEs has never gone away 
(see e.g. Gubbels & Pelkmans, 2009) but merely 
receded  in  the  background  when  the 
Commission  and  the  European  Chemical 
Agency (ECHA) were in the process of building 
and  elaborating  the  REACH  machinery  in 
operational  terms.  This  year,  the  problem  is 
rearing its head again in a magnified fashion and 
it will not go away so easily this time.  
On 5 February 2013, the European Commission 
published  its  review  of  REACH.  It  was 
accompanied  by  a  summary  document  of  15 
pages,  including  a  one-page  appendix  devoted 
exclusively to the potential negative effects that 
REACH may have on SMEs. The first action on 
this review by the Commission was to adapt the 
fee regulation by decreasing REACH registration 
fees  for  SMEs.  A  second  action  was  the 
appointment of an ‘ambassador for SMEs’ within 
ECHA. 
On 25 June 2013, the European Commission also 
organised a workshop to discuss the findings of 
this recent review. One of the main topics was 
the effect of REACH on SMEs. Only one week 
later  Chemical  Watch,  an  online  journal  on 
chemical legislation, organised a webinar on the 
subject  of  REACH  and  SMEs.  On  10  and  11 
December 2013, a follow-up workshop on SMEs 
and REACH is being organised by the European 
Commission.  CEFIC,  representing  the  mayor 
chemical  companies  in  Europe  but  also  some 
SMEs,  is  asking  for  solutions,  thereby  backing 
the  European  Association  of  Craft,  Small  and 
Medium-sized  Enterprises  (UEAPME),  which 
had  already  identified  many  areas  of  concern. 
The EP ITRE Committee will discuss the REACH 
review in a hearing in January 2014 and inspect 
the SME issue. 
In  a  climate  of  renewed  attention  and  targeted 
initiatives  on  REACH  and  SMEs,  this  CEPS 
Policy  Brief  analyses  the  impact  of  REACH  on 
SMEs since its entry into force in June 2007.1 We 
will first explain why REACH is a problem for 
SMEs and subsequently scrutinise in some detail 
seven  elements  of  REACH  implementation 
causing  headaches  for  SMEs.  We  also  ask  the 
question  whether,  against  all  these  costs  and 
problems,  REACH  has  in  store  some  value-
added  for  SMEs.  We  end  this  Brief  with  some 
concluding  remarks  and  a  series  of 
recommendations, assuming as a constraint that 
the  REACH  regulation  as  such  will  not  be 
modified  in  any  fundamental  way  in  the  near 
future.  
                                                   
1 Our findings are based on a review of existing reports 
and literature covering the experiences of SMEs, as well 
as  on  a  set  of  semi-structured  interviews  to  a  small 
sample of SMEs in the chemical sector. The CEPS team 
approached a number of SMEs in chemistry, of which 12 
were eventually interviewed via telephone, based on a 
questionnaire  made  available  beforehand.  This  sample 
cannot be considered “representative” of EU SMEs, but 
allows us to draw a general picture. Interviewed SMEs 
belong  to  the  following  categories:  manufacturers  of 
chemicals, importers of chemicals, formulators, and end 
users  (including  a  non-chemical  textile  SME  and  the 
automotive industry). In addition to the interviews with 
SMEs  representatives  of  CEFIC,  a  national  SME 
Association  and  UEAPME  were interviewed  using  the 
same questionnaire.  REACH: A KILLER WHALE FOR SMES? | 3 
 
2.  Why is REACH a concern for 
SMEs? 
As REACH is a very demanding system for any 
business  either  large  or  small,  the  attention 
ought  to  go  first  and  foremost  to  its  benefits. 
Regulating  in  such  a  heavy  and  intrusive  way 
can  only  be  justified,  if  the  benefits  are 
impressive  and  outweigh  the  costs  by  a  large 
margin.  In  the  case  of  REACH,  precisely  the 
identification and the (very rough) magnitude of 
benefits compared to the regulatory burden is a 
central  issue  that  exacerbates  cynicism  in 
business  circles,  not  least  among  SMEs.  The 
benefits of REACH were hardly addressed in the 
REACH proposal at the time, and the few lines 
devoted to it were solely about health benefits, 
with environmental benefits said to be unknown 
even  as  a  rough  guess  (Gubbels  &  Pelkmans, 
2009, pp. 9-10). Since this unfortunate start, the 
identification  of  future  benefits  has  received 
much  more  attention  and  efforts  (e.g.  by 
Eurostat’s  special  tracking  reports  and  several 
other contributions). However the fundamental 
issue  remains  that  the  benefits  will  only  be 
known  with  some  degree  of  confidence  in  one 
and a half or two decades from now. The costs 
instead are incurred up front, and the concern is 
therefore concentrated on those at the moment.  
A  recent  Commission  consultation  identifies 
REACH  as  the  no.  1  in  a  top-ten  list  of  most 
burdensome pieces of EU legislation for SMEs. 
The  2013  REACH  Review 2 still  speaks  about 
benefits materialising in only ten to twenty years 
and acknowledges that the short-run benefits do 
not  seem  to  match  the  short-run  costs  for 
business.  The  Stoiber  High  Level  Group  on 
Administrative  Burdens  has  also  drawn 
attention to REACH as burdensome.  
In general, it is expected that larger companies 
will  have  more  resources  available  to  comply 
with regulatory demands in comparison to small 
ones.  At  the  first  two  registration  deadlines  of 
REACH in 2010 and 2013, only 13% and 20% of 
the registrations submitted were done by SMEs. 
These numbers may even decrease as ECHA is 
                                                   
2 European Commission, Background report on REACH, 
SWD(2013)25 of 5 February 2013; and General report on 
REACH, accompanying COM (2013) 49 of the same date. 
currently  verifying  the  status  of  registrants 
claiming  to  be  SME. 3  Hence,  to  date  most 
experience  with  REACH  was  built  up  within 
larger  companies  and,  indeed,  on  well-known 
chemicals  with  more  or  less  complete 
information packages. In other words, what has 
been experienced so far is not a good predictor 
of the near future of REACH for SMEs. The 2018 
registration wave is bound to be different: many 
more  chemicals  will  be  involved  with 
incomplete knowledge or even largely unknown 
properties;  also,  far  more  SMEs  will  register 
substances.  The  recently  published  Panteia 
report,4 however, uses SME compliance costs of 
2012  to  calculate  the  future  costs  under  the 
assumption  that  all  SMEs  are  affected  to  the 
same extent (corrected for their size), 
There  are  two  principal  reasons  why  there  is 
serious concern for the position of SMEs when it 
comes to REACH compliance: 
1)  The first is related to an uneven share of the 
costs. SMEs may be relatively disadvantaged 
(compared  to  bigger  or  very  large  firms), 
particularly as they tend to deal with (much) 
lower  volumes  of  chemicals  than  bigger 
firms. This results in higher costs per unit.  
2)  The second is the large number of companies 
affected.  Some  27,600  companies  in  EU 
chemistry  are  SMEs  (95%  of  all  firms).5 In 
2009, SMEs accounted for 28 % of EU sales 
and 35 % of all jobs in the chemical sector.6 
They  represent  a  large  number  of  activities 
ranging from manufacturing, formulating to 
producing and selling ‘articles’. Although the 
impact  of  REACH  on  their  activities  may 
differ  significantly,  the  relative 
disadvantages  multiply  over  a  large  set  of 
                                                   
3  For  further  details,  see  http://echa.europa.eu/ 
support/small-and-medium-sized-enterprises-
smes/sme-verification 
4 Panteia (2013), Impact REACH op MKB, June. 
5  Manufacture_of_chemicals_and_chemical_products_ 
statistics_-_NACE_Rev._2, April 2013. 
6 In the EU more generally, SMEs tend to be important 
engines for job creation: some 85 % of all new jobs in the 
EU generated between 2002 and 2010 were created by 
SMEs, with a relatively stronger contribution by young 
SMEs. 4 | GUBBELS, PELKMANS & SCHREFLER 
 
enterprises  representing  a  huge  total 
turnover and many workers.  
Entrepreneurialism,  something  that  the  EU 
economy  badly  needs  in  times  of  economic 
recession, but is often held to be in short supply 
(at  least,  compared  to  the  US,  for  example),  is 
typically  found  in  SMEs,  especially  the  young 
and  ambitious  ones.7 The  EU  economy  cannot 
afford  that  chemical  SMEs,  expected  to  find 
market  niches  not  yet  filled  by  their  big 
competitors, are discouraged and forego market 
entry  due  to  the  heavy  regulatory  burden  i.e. 
costs of REACH for them. Europe would simply 
lose  its  position  in  innovation  e.g.  in 
nanotechnology, green chemistry and bio-based 
economy.  
As far as the authors know, there have been only 
a few systematic attempts to document the intra-
firm  responses  of  SMEs  to  the  challenges  of 
REACH:  CSES  (2012a)  and  CSES  (2012b), 
addressing  REACH  obligations  in  general  and 
innovation,  respectively. 8  Recently,  Panteia 
(2013)  published  an  additional  report  on  the 
topic  for  the  situation  in  the  Netherlands.  The 
official  REACH  Review  from  the  European 
Commission of 5 February 2013 leans heavily on 
the  CSES  reports  and  contains  no  information 
regarding SMEs additional to these reports. 
In Europe 35% of small and micro firms in the 
sector  created  a  dedicated  REACH-unit,  in 
contrast to 63% of large firms, with 1 to 5 full-
time-equivalents (FTE) for larger firms and less 
than 1 FTE for the smaller companies where the 
relevant  person  also  has  other  responsibilities, 
like Health and Safety (HSE), sales and R&D. In 
SMEs  the  “dedicated”  person  is  in  most  cases 
someone being re-allocated to this task and it is 
not  anticipated  that  REACH  will  lead  to  job 
increases. According to the interviewees, this is 
                                                   
7 R. Veugelers and M. Cincera (2010), “Europe’s missing 
Yollies”,  Bruegel  Policy  Brief  No.  2010/06,  Bruegel, 
Brussels, August. 
8 Centre  for  Strategy  and  Evaluation  Services  (2012a), 
“Interim  Evaluation:  Functioning  of  the  European 
chemical market after the introduction of REACH”, 30 
March; and Centre for Strategy and Evaluation Services 
(2012b) “Study on the impact of REACH Regulation on 
the  innovativeness  of  the  EU  chemical  industry”,  14 
June. 
not  likely  to  change  before  the  2018  deadline, 
when  for  SMEs most  of  the  registration  efforts 
are  expected.  Most  SMEs  use  consultants  for 
registration  activities.  It  is  estimated  that  the 
costs of consultants correspond to some 10 % of 
registration costs, at times more like 10% - 25%. 
Consultants  can  either  be  employed  in  lieu  of 
internal  staff  to  take  care  of  the  entire 
registration  process  for  their  client,  or  as  a 
complement to own human resources, to ensure 
e.g.,  the  legal  or  scientific  soundness  of  the 
reports  prepared  by  the  SME.  These  two  roles 
may  have  different  consequences  for  the 
company,  particularly  as  regards  learning  and 
the  development  of  in-house  REACH  know-
how. After all, REACH compliance does not end 
with  registration,  but  requires  sustained 
attention over time.  
It is, however, a misunderstanding that the share 
of  resources  (both  human  and  financial) 
necessary  to  achieve  REACH  compliance  is 
inversely related to the size of a company. To a 
large extent, the number of substances (dossiers) 
and the number of products produced, imported 
or  formulated  determine  the  size  of  the  SME 
tasks. Note that SMEs tend to have (much) lower 
volumes per substance, even if they might have 
quite  a  few  substances  in  their  portfolio.  This 
leads  to  an  imbalance  between  the  efforts  of 
large  companies  –  typically  with  far  larger 
volumes per substance - versus SMEs, as is also 
reflected by the number of registrations expected 
to be made by SMEs: 82% of the pre-registering 
companies were SMEs (COM (2013) 25), yet only 
a  few  of  these  have  actually  completed  the 
registration  process  up  to  now.  In  addition, 
dealing  with  more  substances  also  implicates 
that more efforts are necessary to communicate 
information along the supply chain. Therefore it 
may be expected that the impact on the internal 
organisation for SMEs is substantial. 
3.  The SME experience with REACH 
compliance 
REACH  is  to  pursue  two  pairs  of  central 
objectives (cf. Art. 1 of the REACH Regulation): 
“a high level of protection of human health and 
the  environment,  as  well  as  enhancing 
competitiveness  and  innovation”.  It  is  an REACH: A KILLER WHALE FOR SMES? | 5 
 
extremely  difficult  balancing  act  to  avoid  or  to 
overcome ‘trade-offs’ between these two sets of 
objectives.  To  date,  from  the  perspective  of 
SMEs,  competitiveness  seems  to  be  the  main 
loser in this equation, particularly as the (largely 
still unknown) benefits in terms of human health 
and  environmental  protection  are  expected  to 
materialise  only  in  the  long  run.  As  a  result, 
REACH  seems  to  lead  to  a  competitive 
disadvantage  for  SMEs,  due  to  costs,  training, 
resources  required,  as  well  as  other  factors 
including  uncertainty  in  the  case  of  some 
substances. In this section, we shall summarise 
today’s  empirical  evidence  based  on  recent 
literature and our own detailed interviews. The 
aspects to be discussed include costs & time-to-
market,  communication  over  the  value-chain, 
changes in business strategy, awareness of what 
compliance  takes,  expected  effects  in  markets, 
SME experience in SIEFs (Substance Information 
Exchange Forum; for a definition see below) and 
SME views of support for REACH compliance.  
So  far  no  clear  evidence  of  changes  in  the 
business models of SMEs is observed. REACH is 
perceived  as  a  constraint  to  innovation, 
negatively  affecting  time-to-market  (CSES 
2012b:60) and limiting the possibility to test new 
uses or substances. Reportedly, companies “take 
into account the REACH cost of any new idea”, 
and discard more projects than they did before, 
as scaling up to test real market potential would 
automatically  trigger  the  need  to  register.  The 
exemption included in the PPORD provision has 
not been used to date by many SMEs.9 
When  looking  at  these  aspects,  it  is  critical  to 
distinguish  chemical  SMEs  (upstream,  such  as 
integrators  and  formulators)  and  SMEs  further 
downstream  which  make  use  of  one  or  more 
chemical substances but otherwise mainly focus 
on their final product. The latter may often be an 
article where the relationship with the chemical 
origin  has  disappeared.  These  products  (e.g., 
textiles,  cars,  furniture,  airplanes,  domestic 
appliances, etc.) are in general not considered as 
chemicals. There are signals that the awareness 
                                                   
9 PPORD (product and process orientated research and 
development):  Pilot  plants  or  production  trials  to 
develop  the  production  process  or  to  test  a  new 
substance are exempted from registration. 
amongst  SMEs  in  those  downstream  industries 
leaves  much  to  be  desired.  In  addition, 
nowadays, many SME traders importing articles 
from  all  over  the  world  can  be  regarded  as 
vulnerable under REACH. They are potentially 
affected by the notification of ‘substances of very 
high concern’ (SVHC) present in their products. 
On  the  other hand, awareness  among  SMEs  in 
the higher parts of the value chain seems to be 
less  of  an  issue.  This  is  also  reflected  in  the 
findings  of  the  Panteia  report.  However,  this 
report  also  indicates  that  even  among  Dutch 
SMEs  identified  as  belonging  to  the  chemical 
industry, 23% are not aware they are affected by 
REACH, 
3.1  Costs and time-to-market 
Costs  and  time  (to-market)  are  important 
restrictions  for market  access  (REACH Review, 
SWD (2013) 25: 127 and further) for SMEs. Major 
sources of costs relate to testing, consultants and 
other  forms  of  support  to  navigate  through 
REACH’s  complexity,  but  costs  related  to 
restructuring  of  existing  plants  in  order  to 
comply  with  stricter  requirements  for 
containment systems may be necessary, too. In 
addition,  the  time  required  to  become  and 
remain  compliant  e.g.  fulfil  processes  like 
volume  tracking,  submission/maintenance  of 
registrations,  preparation  of  SDSs  (safety  data 
sheets)  with  exposure  scenarios  and 
communication up and down the supply chain is 
expensive and may draw attention and resources 
away from other business processes.  
Overall, the cost of REACH compliance is seen 
as considerable from an SME-perspective. 
CSES  shows  that  the  overall  direct  costs  are 
much  higher  than  initially  foreseen:  some  €1.1 
billion (in euros of 2011) in 2003 as against some 
€2.1  billion  today.  The  new  and  more  robust 
estimate, based on empirical evidence this time, 
is  nearly  double  the  amount  in  the  2003 
Commission  Impact  Assessment.  And  in 
absolute  terms  –  no  less  than  €  1  billion  -  this 
difference it is sizeable, too. The difference can 
be attributed to two reasons: 
a)  QSAR  models  (meant  to  be  used  so  as  to 
avoid animal testing) were expected to save 
some €1.3 billion in testing costs, but current 6 | GUBBELS, PELKMANS & SCHREFLER 
 
experience  shows  that  almost  no  savings 
were made in this respect;  
b)  the costs of access to data in a SIEF (for data 
sharing in case of joint registration, based on 
so-called Letters-of-Access [LoA] ) were not 
foreseen.10 
CSES  notes  (2012a:  54-55)  that  the  financial 
situation  of  companies  is  made  more  difficult 
due  to  REACH,  and  this  is  likely  to  bear  on 
strategy.  During  our  interviews,  the  recent 
financial and economic crises were not seen as a 
major  problem  for  REACH  compliance  and 
revision  of  business  models,  except  for  the 
limited availability of finance to fund testing.  
Another issue, widely reported elsewhere (CSES 
2012a:49  and  2012b),  and  confirmed  by  our 
interviewees, is the diversion of R&D resources 
to  REACH-compliance,  which  hampers 
innovation.  Besides  for  direct  work  on 
compliance,  resources  from  R&D  are  also 
increasingly  used  for  investigations  on 
substitution of raw materials, either by replacing 
non-REACH  compliant  suppliers  with  REACH 
compliant suppliers (this, in turn, entails search 
in  the  market,  no  research  itself,  let  alone 
innovation)  or  by  substituting  a  hazardous 
material  with  a  supposedly  non-hazardous 
material  (this  substitution  may,  but  need  not, 
imply innovation). 
3.2  Communication over the value chain 
Extended  Safety  Data  Sheets  (eSDS)  often 
requires  complex  interactions  and  information 
exchange within the supply chain, triggering the 
need  for  IT  tools  to  manage  these  streams 
adequately  and  provide  insight  in  the  ‘bill  of 
materials’.  These  tools  are  available  in  the 
market, but are expensive and need to be tailor-
made  for  the  company.  SMEs  often  have  less 
overview of their tasks and may look for cheap 
solutions that in the end meet only a part of their 
                                                   
10  SIEF  stands  for  Substance  Information  Exchange 
Forum. For further details, see below and I. Gubbels and 
J.  Pelkmans  (2009),  “Is  REACH  going  well?”,  CEPS 
Policy Brief, CEPS, Brussels. 
specific  needs.11 The  administrative  burden  of 
supply  chain  communication  is  large,  as  all 
communications  and  decisions  need  to  be 
documented and may need to be made available 
to the authorities to prove compliance. 
Due  to  the  obligations  to  communicate  within 
the  supply  chain,  relationships  between 
suppliers and downstream users have changed, 
and  in  the  process,  many  companies  struggle 
with  their  confidential  business  information 
(CBI).  This  will  affect  SMEs  in  particular, 
because  often  their  business  depends  on  secret 
recipes  (a  specific  feature  of  a  mixture,  e.g. 
viscosity  is  determined  mainly  by  the  precise 
composite substances present in the mixture and 
perhaps the mere inclusion of one very specific 
chemical).  Knowledge  gained  by  either 
customers or suppliers on the specific chemicals 
present in a mixture, due to communication in 
the  Safety  Data  Sheets  (SDS),  may  provide 
competitors with sufficient information to copy 
products.  
3.3  Changes in business strategy 
With many more SMEs entering the registration 
process  in  2018,  tough  questions  of  re-
structuring  of  product  portfolios  will  become 
apparent, with some substances being dropped 
(‘withdrawn’)  as  they  are  not  economically 
viable  anymore.  Several  of  our  interviewees 
explained  that  they  have  reduced  the  volumes 
they  produce  for  some  substances  (thus, 
remaining below critical thresholds) in order to 
preserve their ability to market them inside the 
EU  (for  a  few  more  years,  until  the  next 
registration  deadline)  and  postpone  potentially 
tough decisions.  
In addition, a side effect of REACH is that some 
substances are identified as ‘substances of very 
high  concern’  (SVHC)  and  now  appear  on  the 
official  candidate  list  of  ECHA  in  order  to  be 
substituted  or  restricted  in  its  use.  Reportedly, 
this already has a negative impact on the market 
today. This ‘chilling effect’ is often reinforced by 
the  appearance  on  unofficial  lists  like  the  SIN 
                                                   
11 It is for this reason that the authors, in the EP ITRE 
report,  added  an  Annex  2,  setting  out  the  ten 
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(Substitute  It  Now)  list  (from  NGOs)  and  the 
European  Trade  Union  Confederation  (ETUC) 
list, functioning de facto as ‘stigmatisation lists’. 
These lists are already used by many companies 
in  order  to  try  to  substitute  raw  materials, 
although not a single authorisation has yet been 
given  or  indeed  refused.  A  general  lack  of 
experience  with  the  (heavy)  authorisation 
process and the uncertainty arising from the first 
day  a  substance  is  listed,  may  lead  to  the 
disappearance of some substances from the EU 
market. 
Some  35%  of  the Dutch  companies  affected  by 
REACH  indicate  that  they  have  started  to  use 
substitutes  during  the  first  years  of  REACH 
(Panteia  2013).  When no  comparable  substitute 
exists,  some  businesses  fear  that  downstream 
users  might  relocate  part  of  the  production 
process  outside  Europe  and  re-import  the 
finished  product  rather  than  incur  the  costs  of 
registration. This is possible because companies 
established  outside  the  EU  can  do  what 
companies  inside  the  EU  cannot.  If  such 
relocation  to  production  sites  outside  Europe 
were to occur, it is likely to lead to job losses in 
the European industry. The painful aspect in all 
this is that the final product after REACH – as it 
is imported – would not be different at all from 
its  pre-REACH  version,  despite  the  substances 
on  the  candidate  list.  In  other  words,  the  job 
losses involved are not a sacrifice for the aim of 
safer chemicals: in fact, under relocation, the job 
losses  are  a  pure  loss  of  social  and  economic 
welfare  for  the  EU  (in  analogy  with  ‘carbon 
leakage’ in climate strategy).  
3.4  Awareness of what compliance takes 
Overall, and as confirmed by the (national and 
EU) associations contacted during our research, 
SMEs  that  display  a  “proactive”  attitude  (e.g., 
split the registration process into various blocks 
across  the  deadlines,  seek  timely  help  from 
different  sources  and/or  follow  trainings, 
coordinate  internally  across  the  various 
departments to elaborate strategies for REACH-
compliance) are likely to survive REACH. From 
our sample, and more generally, it is difficult to 
establish  the  overall  proportion  of  this  type  of 
firms. A worrying feature that emerged as well 
from  interviews  and  was  already  noted  in  the 
Commission’s  review,  is  that  there  are  several 
companies not even having started with REACH 
preparation.  Such  SMEs  tend,  as  one  company 
put it to us, “to bury their head under the sand 
and  hope  that  REACH  will  pass  or  deadlines 
will be postponed. They will wake up too late, 
and then?” 
In  addition,  many  companies  that  do  not 
consider  themselves  as  involved  in  chemicals 
may still be unaware of REACH and its potential 
influence on their compliance. Among these, we 
could  only  interview  one  textile  firm  and  a 
representative of the automotive industry. Even 
in this case, there appear to be differences in the 
degree  of  'preparedness’  to  comply  with 
REACH.  Associations  in  the  automotive  sector 
have  reportedly  been  very  proactive  in  setting 
up information points and dedicated templates 
for their SMEs. This will at the very least ensure 
awareness  of  REACH  requirements  and 
deadlines  among  concerned  firms.  The 
experience in the more fragmented textile sector 
is  likely  to  be  more  mixed,  but  we  have 
insufficient evidence to comment further on this 
case. 
 
3.5  Expected effects in markets 
The CSES study (2012a:54) indicates that 13% - 
18.5%  of  companies  increased  their  prices 
following  the  introduction  of  REACH.  Price 
increases are often in the range of 3% to 5%, but 
Nanomaterials 
For  innovative  SMEs  involved  in  the 
development  of  nanomaterials,  either  on  their 
own or as a subsidiary of a large company, the 
influence  of  REACH  is  expected  not  to  differ 
significantly  from  the  general  picture  as 
described  here.  Since  the  requirements  for 
registration  of nanomaterials  were included in 
the  REACH  guidance  from  ECHA,  at  least 
clarity  has  been  provided.  Although  there  are 
some differences in technical requirements, it is 
expected  that  the  impact  of  registration  costs, 
knowledge and other aspects for nanomaterials 
will  be  to  the  advantage  of  larger  companies. 
None of the interviewees was actively involved 
in  the  development  of  nanomaterials,  which 
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reaching  at  times  25%.  According  to  Panteia 
(2013),  21%  of  the  Dutch  SMEs  with  REACH 
obligations indicate that their prices will increase 
due  to  REACH.  For  article  producers 
(downstream),  this  is  not  such  a  big  problem 
because the chemical value-added in the overall 
product  tends  to  be  very  small.  In  the  CSES 
study, some  37%  of  respondents  indicated  that 
they  have  experienced  withdrawals  of 
substances  and  another  30%  expect  this  to 
happen  in  future.  The  greatest  incentives  for 
withdrawals are the unit costs of registration and 
the  listing  of  substances  as  SVHC  on  the 
candidate  list  and/or  other  non-official  lists. 
Often,  but  not  always,  users  can  switch  to 
another supplier. This will lead to considerable 
costs  as  the  product  sold  by  the  new  supplier 
also needs to be tested to establish that it fulfils 
the product specifications, i.e., the performance 
of  the  substitute  is  similar  or  better  than  the 
performance  of  the  original.  However, 
substitution is not always possible and may lead 
to replacement of chemicals that are hazardous 
by  others  that  are  only  slightly  less  hazardous 
(CSES, 2012b: 67).  
Finally,  there  is  a  lingering  fear  that  costs, 
withdrawals  and  problems  of  substitution 
together will cause a loss of market share vis-à-
vis non-EU producers. However, the report also 
finds  some  contradictory  evidence,  suggesting 
that REACH might force importers to switch to 
EU manufacturers (2012a:66). This last point was 
also mentioned by two of our interviewees, who 
explained  that  in  future  they might  decide  “to 
buy  European”.  Nevertheless,  there  is  not 
enough evidence to draw any firm conclusions 
on this aspect at the moment. 
Generally,  interviewees,  both  SMEs  and  sector 
associations  for  the  chemical  industry,  expect 
that  some  SMEs  (including,  but  not  only, 
traders) will exit from the market by or shortly 
after 2018. This could lead to lower numbers of 
substances,  but  also  to  a  reduction  of  raw 
material  suppliers  and  formulators.  It  is 
expected to lead to job losses in certain segments 
of the market, less competition in some product 
markets  and  selected  price  increases.  As 
mentioned, importers and traders of substances 
and raw materials coming from outside the EU 
are likely to be affected most. 
So  far,  most  respondents  indicated  that  they 
absorb the costs of REACH rather than passing 
them on to their customers. Things might change 
after  2018  when  “who  and  what  is  left  on  the 
market”  becomes  clearer.  Niche  or  specialised 
chemicals (provided they do not disappear due 
to rationalisation) could be sold at higher prices, 
sometimes  becoming  a  source  of  competitive 
advantage  for  such  specialised  SMEs  who  will 
face  fewer  competitors.  For  ‘commodity 
substances’  however,  raising  prices  does  not 
seem to be a feasible option. 
3.6  The Substance Information Exchange 
Fora (SIEF) experience for SMEs 
SIEFs  deal  with  joint  registration  between  a 
number of companies, thereby sharing data and 
expecting  to  reduce  registration  costs  of  each 
specific substance for each market player in that 
group. Feedback on the impact for SMEs when 
participating in SIEFs is mixed. However, views 
converge on one point: the final cost of a SIEF 
and of the concomitant registration for a SME is 
never clear from the start, as it will eventually 
depend on the final number of SIEF participants 
that  share  the  costs.  In  general  due  to  lower 
volumes, unit costs are higher for SMEs than for 
large companies, and when they add up – i.e. if 
there  are  many  substances  –  the  cost 
competitiveness  of  SMEs  becomes  a  serious 
problem.  Moreover,  additional  expenses  will 
have to be incurred when updates of the dossier 
are needed.  
In  the  context  of  the  SIEF,  intentional  or  even 
unintentional abuses of dominance, as also noted 
by  CSES  (2012a:86  and  65),  are  experienced. 
There have been repeated suggestions that lead 
registrants  or  big  firms  in  SIEFs  abuse  their 
dominant  position.  One  of  the  interviewees 
pointed  out  that  this  is  done  by  refusing  to 
update a dossier for a specific endpoint, which is 
of more importance for the SME than for the big 
firms,  e.g.  a  potentially  sensitising  substance 
may prove to be non-sensitising after additional 
testing,  which  may  be  important  for  the  niche 
market of the SME, but not for the raw material 
market of the big firm. The possibilities for opt-
out are limited and very costly. Moreover, LoAs 
are regarded as very expensive, possibly a form 
of exploitative abuse under Art. 102, TFEU.  REACH: A KILLER WHALE FOR SMES? | 9 
 
Although,  in  principle,  all  discussions  and 
actions of the SIEF are subject to EU competition 
law,  the  question  might  be  asked  whether 
REACH  and  guidance  provided  by  the  ECHA 
(as  the  Commission  suggests)  are  sufficient  to 
deal with competition law issues in the SIEF. The 
general rules of competition law are not seen as 
helpful by SMEs, as infringements are difficult to 
prove  and  pursuing  them  requires  time  and 
resources  that  small  companies  do  not  have. 
Moreover, what matters is the outcome of anti-
trust cases and this may take a lot of time; when 
composing  SIEFs  and  racing  for  a  deadline  of 
registration, such time is simply not available.  
During an interview, a UEAPME representative 
suggested  that  a  positive  step  to  increase 
transparency  within  SIEFs,  and  in  the  costs  of 
LoAs (regardless of their magnitude), would be 
an  increased  influence  of  ECHA  and  the 
establishment  of  an  Ombudsman  to  monitor 
more  closely  individual  cases  and  offer  a 
platform for redress to SMEs. Meanwhile, ECHA 
has appointed an ‘SME Ambassador’, who will 
coordinate actions regarding REACH and SMEs 
between industry organisations, ECHA and the 
Commission. 
 
3.7  SME views of support of REACH 
compliance  
SMEs  are  provided  with  various  sources  of 
support  to  comply  with  REACH.  These  range 
from  the  guidance  and  assistance  offered  by 
ECHA  and  the  European  Commission,  to  the 
national  Helpdesks  foreseen  under  REACH,  to 
initiatives set up by sector associations at the EU 
and national level, by Chambers of Commerce, 
and by more informal solutions such as support 
networks  set  up  by  companies.  It  is  worth 
pointing  out  that  there  are  intrinsic  differences 
across EU Member States in terms of resources 
and  available  capacity  to  support  SMEs  with 
REACH compliance.  
The aforementioned forms of support have been 
used  by  practically  all  firms:  ECHA  (92%),  the 
national  helpdesk  (83%),  national  trade 
associations (87%), European Trade Associations 
(69%),  and  private  consultants  (60%)).  When  it 
comes to quality of support (for the companies), 
the national  and  EU  trade/sector  organisations 
(e.g.,  CEFIC’s  guidance  and  templates  were 
often  praised)  are  by  far  the  most  appreciated 
('tailor-made'), closely followed by the European 
Trade  Associations  and  private  consultants. 
ECHA scores weakly and national helpdesks the 
worst  (mixed  among  our  interviewees,  on  this 
point see also the Panteia report). 
As  mentioned  in  other  reports,  the  guidance 
provided  by  ECHA  is  considered  very 
comprehensive but too burdensome for a small 
company. In particular it is difficult to navigate 
through  or  around  the  different  sets  of 
guidelines (altogether, thousands of pages with 
often  highly  specialised  information),  and 
several respondents suggested that a proper and 
user-friendly index/table of contents for all this 
information would be helpful.  
Regarding  IT  tools  like  REACH  IT,  IUCLID, 
CHESAR,  and  the  frequent  updates  of  these 
tools from the ECHA side (the latter was often 
cited  as  a  major  source  of  frustration,  because 
what seems like a minor IT change in Helsinki 
sometimes  requires  re-entering  a  lot  of 
information  on  the  SME-side),  the  cumulative 
effects  on  the  internal  functioning  of  a  small 
company can be considerable. 
What will a REACH ambassador for SMEs do? 
After  the  REACH  review  of  2013,  Andreas 
Herdina,  ECHA  Director  for  Cooperation,  was 
appointed as SME ambassador for REACH. His 
tasks  reflect  to  a  considerable  degree  the  items 
specified in the Annex (on SMEs) to the Review.  
Reviewing SME needs for 2018: 
  Questionnaire  to  SMEs  having  registered  in 
2013 
  Addressing  costs  associated  with  preparing 
registration dossiers 
  Recommendations  on  cost  and  data  sharing 
(especially Letters of Access in SIEFs) together 
with Commission and industry associations 
  Making Guidance more user-friendly 
  More  ‘guidance  in  a  nutshell’,  simpler 
language 
  Revised SME pages on ECHA website 
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4.  Assessing the added value of 
REACH for SMEs 
When assessing what value-added REACH has 
for  SMEs,  if  any,  the  central problem  is  that  it 
would  seem  to  be  too  early  to  come  to 
conclusions, given that several SMEs still have to 
face the bulk of registration efforts between now 
and  2018.  The  overall  acceptance  of  REACH 
among SMEs will only become apparent at the 
end of the three rounds of registration. Yet, our 
interviewees clearly indicate that - for the time 
being - REACH is essentially equated to a surge 
in costs and administrative burdens. This view is 
also  reflected  in  the  recent  position  paper  by 
UEAPME on the REACH review.12  
The  following  benefits  might  be  identified 
(CSES, 2012, a): 
a)  creation and use of new knowledge (70% of 
firms  saw  none  of  this;  11%  stated  that 
REACH has helped develop less hazardous 
substances  or  new  uses);  member  states’ 
authorities  assume  a  radically  different 
position, saying that “the knowledge created 
through  REACH  [is]  fundamental"  and 
“absolutely necessary for authorities”;  
b)  improvement  of  risk  management  and 
occupational  health  and  safety.  How 
(un)important  these  benefits  really  are  is 
unclear. The CSES report also specifies that 
"potential benefits are thus only expected to 
occur  after  2018,  once  registration  related 
costs decrease significantly".  
Among  our  interviewees,  an  improvement  (i.e. 
increased  frequency)  of  the  communication 
within  the  supply  chain  is  seen  as  potentially 
beneficial  regarding  knowledge  of  chemicals 
substances and understanding of customers. One 
manufacturer explained that REACH pushed its 
company to re-assess its containment system and 
the  use  of  protective  personal  equipment. 
Although  compliance  costs  to  redesign  plants 
were  significant,  the  interviewee  believes  that 
the company now understands and handles the 
risks of operating with certain chemicals better. 
                                                   
12  The  Position  Paper  of  May  2013  is  available  at 
http://www.ueapme.com/IMG/pdf/UEAPME_Positio
n_Paper_on_the_REACH_Review.pdf 
Others felt that, to date, this is merely a benefit 
in  terms  of  transparency  rather  than  an 
improvement in the knowledge base. 
It  should  be  noted  that  CSES’  findings  on 
benefits in terms of knowledge transfer are quite 
negative (2012a: 25-26). The quality of SDSs and 
eSDSs  has  been  rather  disappointing.  Another 
set  of  positive  expectations  surrounded  eSDS: 
there  was  a  hope  that  detailed  information  on 
how to use a chemical safely sheet could lead to 
greater  coherence  with  other  legislation  at  the 
EU and national level, for instance in the area of 
labour, so as to avoid duplications. As a matter 
of fact, downstream (SME) users only received a 
very  limited  number  of  extended  safety  data 
sheets;  it  is  therefore  difficult  to  establish 
whether the increased information on chemicals 
and  their  exposure  has  led  to  process 
changes/improvements down the supply chain 
and more specifically to added value for SMEs. 
Some  of  the  smallest  firms  in  our  sample  also 
mentioned  that  the  increasing  availability  of 
information on chemicals on the ECHA website 
allows them to better understand the structure of 
the market in which they operate and potentially 
identify  opportunities  for  future  business 
development. This echoes the findings of CSES’s 
report on innovation (2012b). A few respondents 
saw  this  increased  transparency  as  a  potential 
threat to their business.  
In any event, it is fair to conclude that tangible 
benefits  will  only  be  better  observable  in  the 
future.  
During  the  interviews  with  SMEs  and 
Associations we also asked whether REACH has 
had  any  beneficial  effects  for  the  overall 
reputation of the chemical industry. At the time 
of adoption of the Regulation, this was presented 
as a potential benefit for the sector. It is probably 
too  early  to  observe  such  an  effect.  However, 
some  such  benefits  were  acknowledged  by 
respondents  as  regards  the  reputation  of  the 
chemical sector towards downstream users (B2B, 
not  for  society  at  large).  Conversely,  all 
companies reported that the wider public seems 
to be unaware of the existence of REACH and of 
the  considerable  efforts  undertaken  by  the 
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while incidents in the chemical industry are big 
news items. 
5.  Conclusions on empirical evidence 
REACH  is  widely  regarded  as  burdensome  by 
SMEs. Although the registration process is still 
ongoing,  there  are  already  objective  empirical 
indications that this SME view is correct.  
In  terms  of  human  resources  SMEs  typically 
have  needed  to  commit  up  to  one  FTE  for 
REACH  already  for  years;  this  is  unlikely  to 
change  after  the  registration  deadline  of  2018. 
Larger  SMEs  may  need  to  use  even  more 
resources.  
As shown in recent empirical work on REACH 
compliance,  the  communication  up  and  down 
the value chain can be quite costly and resource-
intensive, due to high frequencies of (thousands 
of)  emails.  There  are  also  problems  with  the 
reading of SDSs and doubts linger among SMEs 
about the utility of the eSDS (certainly given the 
significant efforts to fill them in). 
REACH  might  well  lead  to  changes  in  market 
structure.  Some  withdrawals  may  have 
consequences in this respect, but the complaints 
are  also  about  price  increases  and  the  risk  of 
losing market share vis-à-vis non-EU producers. 
This  last  concern  is  connected  to  a  fear  of 
relocation to outside producers, with job losses 
as a result. Note that the final product would not 
change  and  become  safer  with  the  relocation, 
hence  the  intended  REACH  effect  is 
undermined. 
There are problems with the functioning and the 
costs of SIEFs and with the uncertainty about the 
final  costs  of  participating  in  a  SIEF.  SMEs 
consider that a priori they have no idea what the 
costs will be after the lead registrant will have 
registered.  The  possibilities  to  opt-out  are 
limited and very costly. In addition, there have 
been  many  complaints  that  ‘lead  registrants’  - 
usually big firms as the work is very resource-
intensive over a period of time - or big chemical 
firms in general abuse their dominant position in 
SIEFs,  be  it  via  very  high  fees  for  LoAs  or  via 
other tactics which disadvantage SMEs. 
The communication in the supply chain is seen 
as  very  demanding  and  time  consuming. 
Practically  all  SMEs  use  support  systems  for 
communication in the supply chain and (e)-SDS 
generation but their assessment of the quality is 
rather  critical.  The  fee  reductions  for  SMEs  of 
March 2013 are seen as symbolic, at best, because 
they represent a minuscule fraction of the costs. 
The added value of REACH for SMEs, so far, is 
very  limited  indeed.  Many  SMEs  discern  none 
up to now. Some acknowledge that knowledge is 
increasing  and  that  this  might  be  used  later. 
SMEs  rarely  see  any  improvement  of  the 
reputation  of  the  chemical  sector  as a  result  of 
the  great  efforts  undertaken  under  REACH. 
Frequently, one encounters a sense of bitterness 
in this respect. 
The protection of IP and CBI is not a major issue 
in the SIEFs, but can become a problem in the 
information that needs to be communicated via 
the eSDS. 
6.  Policy recommendations helping 
SMEs in REACH 
It is clear that SMEs suffer under REACH. But, 
since full REACH implementation takes no less 
than 11 years until the end of 2018, the status-
quo acts like a trap: it is seen as ‘impossible’ to 
alter  or  redesign  REACH  halfway  into  the 
process.  This  is  also  the  view  of  some  SMEs 
amongst our interviewees for the simple reason 
that,  in  the  short  run,  it  would  only  add  to 
uncertainty and this is undesirable. Assuming no 
significant  changes  in  REACH,  the  authors 
suggest the following policy recommendations: 
  With  respect  to  the  question  of  SIEFs  and 
Letters  of  Access,  one  of  the  solutions  put 
forward  is  to  set-up  a  neutral  and  official 
forum  (within  ECHA)  to  define  templates 
and  perhaps  even  fix  LoA  fees.  SMEs  with 
their  comparatively  lower  know-how  and 
available resources may be faced with “take 
it or leave it” situations as regards the price 
of a LoA or with other potential abuses that 
are difficult to prove. 
  Address  the  potential  competition  law 
implications  of  current  SIEF  arrangements 
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more  thoroughly;  one  option  would  be  a 
Guidance  document  from  DG  Competition 
by 2014 (in time for 2018). 
 
  Review the content and format of Safety Data 
Sheets  (especially  its  extended  form,  the 
eSDS)  which  are  reportedly  not  fulfilling 
their  knowledge  transfer  role  in  a  SME 
context. 
  Providing IT systems to generate compliant 
SDSs  is  necessary.  Perhaps  this  could  be  a 
joint action of authorities and industries (as 
was done by the development of IUCLID). 
  Updates to IT tools online format should be 
kept to a minimum.  
  Improve the communication of REACH and 
its  intended  goals,  that  is,  the  health  and 
environmental benefits, to the wider public. 
SMEs regret the unawareness of the public in 
the light of the enormous efforts they have to 
undertake. 
  While  existing  ECHA  support  is  well 
appreciated – though regarded as ‘heavy’- , 
improvement  of  navigation  through 
guidance  documents  provided  by  ECHA  is 
urgently requested.  
  In the event of a later review of REACH, the 
logic  (especially  related  to  SVHC/ 
authorisation)  should  be  risk-based  rather 
than  hazard-based.  The  hazard  bias  in 
REACH  generates  immediate  fears  in  the 
market  once  a  substance  appears  on  the 
candidate  list  for  authorisations,  although 
risks  might  be  controllable  and  the  socio-
economic  impact  analysis supportive  of  the 
continuation of the use of the substance. 
It  is  expected  that  at  least  some  of  these 
recommendations  will  receive  a  follow-up  and 
part  of  the  problems  faced  by  SMEs  will  be 
addressed during the next few years. However, 
this will merely diminish the burden for SMEs, 
because  REACH  compliance  remains  complex, 
costly and may entail serious consequences for 
the survival  of  individual  SMEs. It  is  therefore 
imperative for SMEs to start early and develop a 
strategy for compliance before 2018.  
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